Bar-Shalev Amos 4
4 · Protalix BioTherapeutics, Inc. · Filed Nov 19, 2025
Insider Transaction Report
Form 4
Bar-Shalev Amos
Director
Transactions
- Sale
Common Stock
2025-11-18$1.87/sh−168$314→ 0 total
Holdings
- 7,500(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued under the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended must be registered in the name of a trustee.